Investor Relations

Event Details

AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy

October 2, 2023 from 4:45 PM to 7:00 PM EDT

Poster Title: Synergistically Engaging a β-Selective IL-2 Agonist with PD1/PDL-1 Blockade in a Bifunctional Superkine, MDNA223.
Poster number: A005
Poster session
: October 2nd, 2023 from 4.45 PM ET – 7.00 PM ET


Toronto, Canada